Bollano E, Andreassen AK, Eiskjaer H, Gustafsson F, et al. Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial. J Heart Lung Transplant 2024 Jul 20:S1053-2498(24)01732.
PMID: 39038562